Maximising the public health benefit of antimalarials

Ric Price, Nicholas (Nick) DOUGLAS

Research output: Contribution to journalComment/debateResearch

Abstract

[No abstract available]
Original languageEnglish
Pages (from-to)654-655
Number of pages2
JournalLancet Infectious Diseases
Volume10
Issue number10
DOIs
Publication statusPublished - 1 Oct 2010

Fingerprint

Antimalarials
Insurance Benefits
Public Health

Cite this

Price, Ric ; DOUGLAS, Nicholas (Nick). / Maximising the public health benefit of antimalarials. In: Lancet Infectious Diseases. 2010 ; Vol. 10, No. 10. pp. 654-655.
@article{0d4b45b1482a42c6a10215127e594ff6,
title = "Maximising the public health benefit of antimalarials",
abstract = "[No abstract available]",
keywords = "amodiaquine plus artesunate, antimalarial agent, artemether plus benflumetol, artesunate, artesunate plus mefloquine, dihydroartemisinin plus piperaquine, mefloquine, piperaquine, primaquine, artemisin, artemisinin derivative, lactone, antimalarial activity, antimalarial drug resistance, clinical trial, disease transmission, drug efficacy, gametocyte, glucose 6 phosphate dehydrogenase deficiency, hemolysis, human, letter, malaria falciparum, mixed infection, parasite control, Plasmodium falciparum, Plasmodium vivax, Plasmodium vivax malaria, priority journal, single drug dose, drug combination, drug effects, malaria, Plasmodium, procedures, Antimalarials, Artemisinins, Drug Therapy, Combination, Humans, Lactones, Malaria",
author = "Ric Price and DOUGLAS, {Nicholas (Nick)}",
year = "2010",
month = "10",
day = "1",
doi = "10.1016/S1473-3099(10)70192-4",
language = "English",
volume = "10",
pages = "654--655",
journal = "The Lancet Infectious Diseases",
issn = "1473-3099",
publisher = "The Lancet Publishing Group",
number = "10",

}

Maximising the public health benefit of antimalarials. / Price, Ric; DOUGLAS, Nicholas (Nick).

In: Lancet Infectious Diseases, Vol. 10, No. 10, 01.10.2010, p. 654-655.

Research output: Contribution to journalComment/debateResearch

TY - JOUR

T1 - Maximising the public health benefit of antimalarials

AU - Price, Ric

AU - DOUGLAS, Nicholas (Nick)

PY - 2010/10/1

Y1 - 2010/10/1

N2 - [No abstract available]

AB - [No abstract available]

KW - amodiaquine plus artesunate

KW - antimalarial agent

KW - artemether plus benflumetol

KW - artesunate

KW - artesunate plus mefloquine

KW - dihydroartemisinin plus piperaquine

KW - mefloquine

KW - piperaquine

KW - primaquine

KW - artemisin

KW - artemisinin derivative

KW - lactone

KW - antimalarial activity

KW - antimalarial drug resistance

KW - clinical trial

KW - disease transmission

KW - drug efficacy

KW - gametocyte

KW - glucose 6 phosphate dehydrogenase deficiency

KW - hemolysis

KW - human

KW - letter

KW - malaria falciparum

KW - mixed infection

KW - parasite control

KW - Plasmodium falciparum

KW - Plasmodium vivax

KW - Plasmodium vivax malaria

KW - priority journal

KW - single drug dose

KW - drug combination

KW - drug effects

KW - malaria

KW - Plasmodium

KW - procedures

KW - Antimalarials

KW - Artemisinins

KW - Drug Therapy, Combination

KW - Humans

KW - Lactones

KW - Malaria

UR - http://www.scopus.com/inward/record.url?scp=77957141394&partnerID=8YFLogxK

U2 - 10.1016/S1473-3099(10)70192-4

DO - 10.1016/S1473-3099(10)70192-4

M3 - Comment/debate

VL - 10

SP - 654

EP - 655

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

SN - 1473-3099

IS - 10

ER -